Poliovirus receptor-related 1
Poliovirus receptor-related 1 (PVRL1), also known as Nectin-1, is a protein that in humans is encoded by the PVRL1 gene. It is a cell adhesion molecule involved in the formation of adherens junctions, and plays a crucial role in the pathogenesis of several diseases, including poliomyelitis and herpes simplex infection.
Structure[edit]
PVRL1 is a member of the nectin and nectin-like (Necl) family of proteins, which are related to the immunoglobulin superfamily. It is a type I transmembrane protein with three extracellular immunoglobulin-like domains, a single transmembrane domain, and a cytoplasmic tail. The extracellular domains are involved in cell adhesion and virus binding, while the cytoplasmic tail interacts with the actin cytoskeleton through afadin, a PDZ domain-containing protein.
Function[edit]
PVRL1 functions as a cell adhesion molecule, mediating cell-cell interactions and regulating cell polarity and tissue architecture. It is involved in the formation of adherens junctions, a type of cell junction that connects the actin cytoskeletons of neighboring cells. PVRL1 also serves as a receptor for certain viruses, including poliovirus and herpes simplex virus.
Clinical significance[edit]
Mutations in the PVRL1 gene are associated with Cleft lip and palate/ectodermal dysplasia syndrome, a rare genetic disorder characterized by cleft lip and/or palate, ectodermal dysplasia, and other abnormalities. PVRL1 is also implicated in the pathogenesis of several viral diseases. It serves as a receptor for poliovirus, facilitating the virus's entry into cells. In addition, PVRL1 is a receptor for herpes simplex virus, and its expression is upregulated in herpes simplex virus-infected cells.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian